FIELD: medicine.
SUBSTANCE: present group of inventions concerns medicine, namely, psychiatry, and includes methods of treatment of schizophrenia at patients with superfluous mass of a body and application of azenapin for manufacturing of the medicine for treatment of this pathological condition.
EFFECT: effective treatment of schizophrenia in the absence of characteristic for other antipsychotic preparations of augmentation of mass of a body.
12 cl, 1 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| OVERWEIGHT OR OBESITY REDUCTION | 2007 |
|
RU2443417C2 |
| PHARMACEUTICAL COMBINATION FOR TREATING AND/OR PREVENTING DISORDERS RELATED TO OVERWEIGHT AND/OR OBESITY, AND BASED METHOD OF TREATING | 2014 |
|
RU2552926C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIPSYCHOTIC, ANTIDEPRESSANT AND ANTIEPILEPTIC ACTIVITY WITH REDUCED SIDE EFFECT | 2007 |
|
RU2440116C2 |
| METHODS OF TREATING OVERWEIGHT OR OBESITY | 2015 |
|
RU2696494C2 |
| USING CANNABINOIDS COMBINED WITH ANTIPSYCHOTIC DRUG PREPARATION | 2008 |
|
RU2503448C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTIPSYCHOTIC DRUG AND A VMAT2 INHIBITOR, AND THEIR USE | 2015 |
|
RU2757221C2 |
| NEW THERAPEUTIC COMBINATIONS OF MIRTAZAPINE AND ANTIPSYCHOTIC AGENTS FOR TREATMENT OR PROPHYLAXIS OF PSYCHOTIC DISORDERS | 1998 |
|
RU2222330C2 |
| MIXTURE CONTAINING CARBAMATE COMPOUND FOR PREVENTION, RELIEF OR TREATMENT OF SCHIZOPHRENIA | 2018 |
|
RU2772465C2 |
| COMPOSITIONS AND METHODS FOR REDUCING SERIOUS ADVERSE CARDIOVASCULAR EVENTS | 2014 |
|
RU2711638C2 |
| ETHYLEICOSAPENTAENOIC ACID OF HIGH PURITY DEGREE AND OTHER DERIVATIVES OF EICOSAPENTAENOIC ACID FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS | 2000 |
|
RU2260423C2 |
